Podiatrists in Huntington Beach, CA Accepting Medicare

27 Podiatrists found. Showing 21 - 27

Dr. Christina Chauncey, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 17822 Beach Blvd, Suite # 352, Huntington Beach, CA 92647 Phone: 714-848-8998

Wesley M Kobayashi Dpm Incorporated Podiatrist Medicare: Medicare Enrolled Practice Location: 18800 Main St, Suite 104, Huntington Beach, CA 92648 Phone: 714-841-1963    Fax: 714-841-6919

David W. Hellewell, D.p.m. Inc Podiatrist - Foot Surgery Medicare: Not Enrolled in Medicare Practice Location: 17822 Beach Blvd Ste 407, Huntington Beach, CA 92647 Phone: 714-841-3213    Fax: 714-841-0434

David Hellewell, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 17822 Beach Blvd, #407, Huntington Beach, CA 92647 Phone: 714-841-3213

Ms. Elham Elle Farajian, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 17822 Beach Blvd, Suite 437, Huntington Beach, CA 92647 Phone: 714-842-7277    Fax: 714-841-8387

Giao T Nguyen Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 5911 Heil Ave, Suite F, Huntington Beach, CA 92649 Phone: 714-377-2255

Keith E Penera, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 19066 Magnolia St, Huntington Beach, CA 92646 Phone: 714-968-0068

News Archive

Salk researchers receive BRAIN Initiative funding

Joseph Ecker, a Salk professor and Howard Hughes Medical Institute investigator, and Margarita Behrens, Salk staff scientist, have been named recipients in the 2014 round of grants from the National Institutes of Health (NIH) through the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative for leading-edge work in neuroscience.

Researchers discover lack of oxygen in the lungs after mold invasion

Researchers led by Montana State University have found a surprising condition that occurs in the lungs after an invasion of a common mold that can cause deadly infections in humans.

NBSTRN develops new tool for newborn screening researchers

After one-and-a-half years of intense development, end-user testing, a successful pilot, and through a contract to the American College of Medical Genetics and Genomics (ACMG) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the Newborn Screening Translational Research Network (NBSTRN) Coordinating Center has developed a centralized, web-based virtual repository of newborn dried blood spots (DBS) as an indispensable tool for newborn screening researchers.

Results of custirsen Phase 2 trial for advanced prostate cancer published in Journal of Clinical Oncology

OncoGenex Pharmaceuticals, Inc. announced today publication of results from a randomized Phase 2 trial in the Journal of Clinical Oncology. The trial results showed a survival benefit with the investigational agent OGX-011/TV1011 (custirsen) in patients with advanced prostate cancer. The median overall survival for patients who were treated with custirsen plus first-line docetaxel/prednisone was 23.8 months compared to 16.9 months for patients treated with docetaxel/prednisone alone.

Read more Medical News

› Verified 3 days ago

• 1
• 2(current)